chimeric antigen receptor T (CART) cell therapyMayo Clinic Division of HematologyMayo Clinic Center for Individualized Medicine4-1BBMayo Clinic
…Background Despite the high initial responses to chimeric antigen receptor T (CART) cell therapy, most patients relapse within the first 1-2 years. Patient-deri…